FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease
Open Access
- 22 August 2024
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (9) , 2221-2233
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
This publication has 58 references indexed in Scilit:
- Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver DiseaseCurrent Obesity Reports, 2022
- TNF in the liver: targeting a central player in inflammationSeminars in Immunopathology, 2022
- Molecular insights into the role of mitochondria in non-alcoholic fatty liver diseaseArchives of Pharmacal Research, 2019
- The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic SteatohepatitisHepatology, 2019
- Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research GapsHepatology, 2019
- Fibronectin Type III Domain Containing 4 attenuates hyperlipidemia-induced insulin resistance via suppression of inflammation and ER stress through HO-1 expression in adipocytesBiochemical and Biophysical Research Communications, 2018
- Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2018
- Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in SteatohepatitisCell Metabolism, 2015
- NLRP3 inflammasome activation is required for fibrosis development in NAFLDJournal of Molecular Medicine, 2014
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005